+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Personalized Nanotechnology for Cell & Gene Therapies Market by Therapy Type, Nanotechnology Type, Application, End User - Global Forecast to 2030- Product Image
Personalized Nanotechnology for Cell & Gene Therapies Market by Therapy Type, Nanotechnology Type, Application, End User - Global Forecast to 2030- Product Image
Sale

Personalized Nanotechnology for Cell & Gene Therapies Market by Therapy Type, Nanotechnology Type, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 187 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6055636
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The rapid advancement of personalized nanotechnology is reshaping the landscape of cell and gene therapies, providing new solutions for complex diseases. By bridging the gap between nanoscience and patient-specific treatment modalities, organizations now have a unique opportunity to drive therapeutic innovation, differentiation, and long-term value.

Market Snapshot: Personalized Nanotechnology for Cell & Gene Therapies

The Personalized Nanotechnology for Cell & Gene Therapies Market grew from USD 855.08 million in 2024 to USD 1.00 billion in 2025. It is expected to continue growing at a CAGR of 19.29%, reaching USD 2.46 billion by 2030.

Scope & Segmentation in the Personalized Nanotechnology Market

Our analysis comprehensively details core segments and geographic markets, empowering stakeholders to understand commercial dynamics and competitive differentiation:

  • Therapy Types: Cell Therapy (including Immune Cell, Induced Pluripotent Stem Cells, Mesenchymal Stem Cells, and Stem Cell Therapy) and Gene Therapy (covering CRISPR Technology, various Delivery Mechanisms, Gene Modification Methods, and the use of Non-Viral Vectors).
  • Nanotechnology Types: Nanocarrier Design, Nanodevices, Nanoencapsulation, Nanomaterials, Nanomedicine, and Nanostructure Imaging.
  • Applications: Cancer Therapies, Cardiovascular Diseases, Inherited Genetic Disorders, and Neurological Disorders.
  • End Users: Diagnostic Centers, Healthcare Facilities, Pharmaceutical Companies, and Research Institutions.
  • Regions: Americas (including major national markets), Europe, Middle East & Africa (with emphasis on regulatory diversity and market maturity), and Asia-Pacific (highlighting rapid industrial scaling and clinical adoption).
  • Leading Companies: AbbVie, Amgen, Arcturus Therapeutics, AstraZeneca, BASF Pharma Solutions, BlueWillow Biologics, Bristol-Myers Squibb, Camurus AB, Celgene, Cristal Therapeutics, Cytimmune Sciences, Eisai Co., EyePoint Pharmaceuticals, Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche, Ipsen Pharma, Johnson & Johnson, Merck KGaA, Nanobiotix, Novartis, Pfizer, Spark Therapeutics, Teva Pharmaceutical Industries, and Thermo Fisher Scientific.

Key Takeaways for Decision-Makers

  • Integration of advanced nanocarrier and encapsulation strategies is driving significant enhancements in the precision and safety profiles of cell and gene therapies.
  • Collaboration across nanotechnologists, genetic researchers, and clinicians accelerates the translation of discoveries into scalable production, impacting commercialization timelines and manufacturing efficiencies.
  • Platform adaptability is increasingly critical, with organizations focusing on interoperable nanotechnology designs that can support diverse therapeutic payloads.
  • Early regulatory engagement and transparent nanomaterial documentation simplify complex approval journeys, particularly as global agencies adapt their quality standards.
  • Regional investment trends show North America and Asia-Pacific maintaining momentum via innovation hubs and government initiatives, while EMEA emphasizes harmonized safety requirements and infrastructure expansion.

2025 US Tariff Impact: Navigating New Cost Pressures

  • Recent US tariff schedules on key imported nanomaterials and specialty reagents have prompted companies to reexamine supply chains and cost structures.
  • Manufacturers are expanding domestic sourcing, optimizing reagent usage, and forming new partnerships with local suppliers to safeguard project timelines and control expenses.
  • Operational resilience is being strengthened through strategic stockpiling, investments in in-house synthesis, and utilization of free trade zones to counterbalance customs delays and logistical disruptions.

Methodology & Data Sources

This research leverages mixed-methods analysis, integrating in-depth secondary research from peer-reviewed journals, patents, regulatory filings, and proprietary industry reports with targeted primary insights from interviews with R&D leaders, manufacturing heads, clinicians, and regulatory consultants. Data triangulation ensures all findings are validated, accurate, and actionable for strategic decisions.

Why This Report Matters to Senior Leaders

  • Enables evidence-based portfolio optimization and risk mitigation by providing actionable insights into transformative technologies, operational best practices, and evolving regulatory landscapes in personalized nanotechnology for cell & gene therapies.
  • Equips executive teams to anticipate market shifts, prioritize investment across segments, and accelerate product development while ensuring compliance with global quality standards and tariff changes.

Conclusion

The future of cell and gene therapy innovation is grounded in multidisciplinary collaboration, adaptable nanotechnology platforms, and resilient supply chain strategies. Organizations that integrate these approaches will sustain growth, realize clinical impact, and lead the next generation of personalized medicine.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of chronic diseases globally
5.1.1.2. Increasing adoption of precision medicine worldwide
5.1.1.3. Government and regulatory support amplifying research and innovations in nanotechnology applications
5.1.2. Restraints
5.1.2.1. High research and development costs associated with nanotechnology in cell and gene therapies
5.1.3. Opportunities
5.1.3.1. Ongoing innovations in leveraging nanotechnology in orally administered gene therapies
5.1.3.2. Development of targeted nano-delivery systems
5.1.4. Challenges
5.1.4.1. Navigating regulatory complexities in personalized nanotechnology for cell and gene therapies
5.2. Market Segmentation Analysis
5.2.1. Therapy Type: Proliferating need for immune cell therapy for personalized treatments
5.2.2. Application: Rising significance of nanotechnology in cancer therapies
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Personalized Nanotechnology for Cell & Gene Therapies Market, by Therapy Type
6.1. Introduction
6.2. Cell Therapy
6.2.1. Immune Cell Therapy
6.2.2. Induced Pluripotent Stem Cells
6.2.3. Mesenchymal Stem Cells
6.2.4. Stem Cell Therapy
6.3. Gene Therapy
6.3.1. CRISPR Technology
6.3.2. Delivery Mechanisms
6.3.3. Gene Modification Methods
6.3.4. Non-Viral Vectors
7. Personalized Nanotechnology for Cell & Gene Therapies Market, by Nanotechnology Type
7.1. Introduction
7.2. Nanocarrier Design
7.3. Nanodevices
7.4. Nanoencapsulation
7.5. Nanomaterials
7.6. Nanomedicine
7.7. Nanostructure Imaging
8. Personalized Nanotechnology for Cell & Gene Therapies Market, by Application
8.1. Introduction
8.2. Cancer Therapies
8.3. Cardiovascular Diseases
8.4. Inherited Genetic Disorders
8.5. Neurological Disorders
9. Personalized Nanotechnology for Cell & Gene Therapies Market, by End User
9.1. Introduction
9.2. Diagnostic Centers
9.3. Healthcare Facilities
9.4. Pharmaceutical Companies
9.5. Research Institutions
10. Americas Personalized Nanotechnology for Cell & Gene Therapies Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Personalized Nanotechnology for Cell & Gene Therapies Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Personalized Nanotechnology for Cell & Gene Therapies Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2024
13.2. FPNV Positioning Matrix, 2024
13.3. Competitive Scenario Analysis
13.3.1. Poseida Therapeutics agreed to be acquired by Roche Holdings
13.3.2. Envoya's nanoparticle technology significantly enhances nucleic acid encapsulation
13.3.3. Cellevate to re-launch its innovative Cellevat3d nanofiber microcarriers
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET MULTI-CURRENCY
FIGURE 2. PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET MULTI-LANGUAGE
FIGURE 3. PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET RESEARCH PROCESS
FIGURE 4. PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, 2024 VS 2030
FIGURE 5. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 9. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 11. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 13. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 15. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 17. AMERICAS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 19. UNITED STATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 24. PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 25. PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET DYNAMICS
TABLE 7. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY IMMUNE CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CRISPR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY DELIVERY MECHANISMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE MODIFICATION METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NON-VIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOCARRIER DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANODEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOENCAPSULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOMEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOSTRUCTURE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CANCER THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY INHERITED GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY HEALTHCARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. CANADA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 57. CANADA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 58. CANADA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 59. CANADA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 60. CANADA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. CANADA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. MEXICO PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 63. MEXICO PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 64. MEXICO PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 65. MEXICO PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 66. MEXICO PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. MEXICO PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 84. AUSTRALIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 85. AUSTRALIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 86. AUSTRALIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. CHINA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 89. CHINA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 90. CHINA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 91. CHINA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 92. CHINA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. CHINA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. INDIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 95. INDIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 96. INDIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 97. INDIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 98. INDIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. INDIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. INDONESIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 101. INDONESIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 102. INDONESIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 103. INDONESIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 104. INDONESIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. INDONESIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. JAPAN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 107. JAPAN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 108. JAPAN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 109. JAPAN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 110. JAPAN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. JAPAN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. MALAYSIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 113. MALAYSIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 114. MALAYSIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 115. MALAYSIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 116. MALAYSIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. MALAYSIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. PHILIPPINES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 119. PHILIPPINES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 120. PHILIPPINES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 121. PHILIPPINES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 122. PHILIPPINES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. PHILIPPINES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. SINGAPORE PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 125. SINGAPORE PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 126. SINGAPORE PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 127. SINGAPORE PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 128. SINGAPORE PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. SINGAPORE PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 131. SOUTH KOREA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 132. SOUTH KOREA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 133. SOUTH KOREA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 134. SOUTH KOREA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. SOUTH KOREA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 137. TAIWAN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 138. TAIWAN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 139. TAIWAN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 140. TAIWAN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. TAIWAN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. THAILAND PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 143. THAILAND PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 144. THAILAND PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 145. THAILAND PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 146. THAILAND PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. THAILAND PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 149. VIETNAM PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 150. VIETNAM PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 151. VIETNAM PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 152. VIETNAM PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. VIETNAM PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 161. DENMARK PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 162. DENMARK PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 163. DENMARK PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 164. DENMARK PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 165. DENMARK PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. DENMARK PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. EGYPT PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 168. EGYPT PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 169. EGYPT PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 170. EGYPT PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 171. EGYPT PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. EGYPT PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. FINLAND PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 174. FINLAND PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 175. FINLAND PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 176. FINLAND PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 177. FINLAND PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. FINLAND PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. FRANCE PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 180. FRANCE PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 181. FRANCE PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 182. FRANCE PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 183. FRANCE PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. FRANCE PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. GERMANY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 186. GERMANY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 187. GERMANY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 188. GERMANY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 189. GERMANY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. GERMANY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 192. ISRAEL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 193. ISRAEL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 194. ISRAEL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 195. ISRAEL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. ISRAEL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. ITALY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 198. ITALY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 199. ITALY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 200. ITALY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 201. ITALY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. ITALY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. NORWAY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 216. NORWAY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 217. NORWAY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 218. NORWAY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 219. NORWAY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. NORWAY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. POLAND PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 222. POLAND PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 223. POLAND PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 224. POLAND PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 225. POLAND PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. POLAND PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. QATAR PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 228. QATAR PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 229. QATAR PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 230. QATAR PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 231. QATAR PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. QATAR PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. RUSSIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 248. SOUTH AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. SOUTH AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. SPAIN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 252. SPAIN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 253. SPAIN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 254. SPAIN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 255. SPAIN PERSONALIZED NANOTECHNOLOGY FO

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Personalized Nanotechnology for Cell & Gene Therapies market report include:
  • AbbVie Inc.
  • Amgen Inc.
  • Arcturus Therapeutics, Inc.
  • AstraZeneca PLC
  • BASF Pharma Solutions
  • BlueWillow Biologics Inc.
  • Bristol-Myers Squibb Company
  • Camurus AB
  • Celgene, Inc.
  • Cristal Therapeutics
  • Cytimmune Sciences
  • Eisai Co., Ltd.
  • EyePoint Pharmaceuticals
  • Gilead Sciences Inc.
  • GlaxoSmithKline PLC
  • Hoffmann-La Roche Ltd
  • Ipsen Pharma
  • Johnson & Johnson
  • Merck KGaA
  • Nanobiotix SA
  • Novartis AG
  • Pfizer Inc.
  • Spark Therapeutics, Inc.
  • Teva Pharmaceutical Industries Limited
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages187
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.46 Billion
Compound Annual Growth Rate19.2%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Personalized Cell & Gene Therapies Market by Therapy Type, Patient Type, Therapeutic Area, End User - Global Forecast to 2030 - Product Image

Personalized Cell & Gene Therapies Market by Therapy Type, Patient Type, Therapeutic Area, End User - Global Forecast to 2030

  • Report
  • 180 Pages
  • Global
From
Cell & Gene Therapy Manufacturing Services Market by Service Type, Technology Type, Therapeutic Area, Application, End-User - Global Forecast to 2030 - Product Image

Cell & Gene Therapy Manufacturing Services Market by Service Type, Technology Type, Therapeutic Area, Application, End-User - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From
Gene Transfer Technologies Market by Product (Instruments, Kits, Assays), Mode (Viral (Retrovirus, Adenovirus, AAV), Non-viral (Electroporation, Gene Gun)), Method (In-Vivo, In-vitro), Application, (Gene Therapy, Research) - Global Forecast to 2029 - Product Image

Gene Transfer Technologies Market by Product (Instruments, Kits, Assays), Mode (Viral (Retrovirus, Adenovirus, AAV), Non-viral (Electroporation, Gene Gun)), Method (In-Vivo, In-vitro), Application, (Gene Therapy, Research) - Global Forecast to 2029

  • Report
  • 525 Pages
  • Global
From
Cell and Gene Therapy Third-Party Logistics Market Size, Share & Trends Analysis Report by Type (Clinical), Product (Cell Therapies, Gene Therapies), Temperature Range (Ambient Storage), Therapeutic Area, End-use, Region, with Growth Forecasts, 2025-2030 - Product Image

Cell and Gene Therapy Third-Party Logistics Market Size, Share & Trends Analysis Report by Type (Clinical), Product (Cell Therapies, Gene Therapies), Temperature Range (Ambient Storage), Therapeutic Area, End-use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Gene Therapy Market Outlook to 2029 - Product Image

Gene Therapy Market Outlook to 2029

  • Report
  • 83 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.